JP2010513320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513320A5 JP2010513320A5 JP2009541645A JP2009541645A JP2010513320A5 JP 2010513320 A5 JP2010513320 A5 JP 2010513320A5 JP 2009541645 A JP2009541645 A JP 2009541645A JP 2009541645 A JP2009541645 A JP 2009541645A JP 2010513320 A5 JP2010513320 A5 JP 2010513320A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- pirfenidone
- days
- pharmaceutical composition
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical compound C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 claims description 69
- 229960003073 pirfenidone Drugs 0.000 claims description 69
- 230000002354 daily effect Effects 0.000 claims description 55
- 239000007858 starting material Substances 0.000 claims description 46
- 239000002775 capsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 229940017668 pirfenidone 267 mg Drugs 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 230000003203 everyday effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 30
- 239000000203 mixture Substances 0.000 claims 7
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 210000000026 apposition eye Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 description 29
- 239000003814 drug Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87059306P | 2006-12-18 | 2006-12-18 | |
| PCT/US2007/087988 WO2008077068A1 (en) | 2006-12-18 | 2007-12-18 | Method of providing pirfenidone therapy to a patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010513320A JP2010513320A (ja) | 2010-04-30 |
| JP2010513320A5 true JP2010513320A5 (cg-RX-API-DMAC7.html) | 2011-02-17 |
Family
ID=39259551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541645A Pending JP2010513320A (ja) | 2006-12-18 | 2007-12-18 | ピルフェニドン治療を患者に提供する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (9) | US7767700B2 (cg-RX-API-DMAC7.html) |
| EP (4) | EP3053580B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010513320A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE506060T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2667654C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1111699T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602007014113D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2124945T3 (cg-RX-API-DMAC7.html) |
| ES (3) | ES2581844T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009006526A (cg-RX-API-DMAC7.html) |
| PL (2) | PL2124945T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2124945E (cg-RX-API-DMAC7.html) |
| SI (1) | SI2124945T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008077068A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008077068A1 (en) | 2006-12-18 | 2008-06-26 | Intermune, Inc. | Method of providing pirfenidone therapy to a patient |
| AU2012205256B2 (en) * | 2008-11-10 | 2015-05-28 | Intermune, Inc. | Pirfenidone Treatment for Patients with Atypical Liver Function |
| US7635707B1 (en) * | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| US7566729B1 (en) | 2008-11-10 | 2009-07-28 | Intermune, Inc. | Modifying pirfenidone treatment for patients with atypical liver function |
| EP2389227A4 (en) * | 2009-01-26 | 2012-08-08 | Intermune Inc | METHOD FOR THE TREATMENT OF ACUTE MYOCARDINE CARDS AND ASSOCIATED ILLNESSES THEREOF |
| US8084475B2 (en) | 2009-12-04 | 2011-12-27 | Intermune, Inc. | Pirfenidone therapy and inducers of cytochrome P450 |
| US7816383B1 (en) | 2009-12-04 | 2010-10-19 | Intermune, Inc. | Methods of administering pirfenidone therapy |
| HUE058753T2 (hu) | 2011-01-31 | 2022-09-28 | Avalyn Pharma Inc | Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik |
| US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| MX2011007675A (es) * | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| CA2819967C (en) * | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
| HK1220133A1 (zh) | 2013-03-15 | 2017-04-28 | Intermune, Inc. | 改善微血管完整性的方法 |
| USD731783S1 (en) | 2014-04-16 | 2015-06-16 | Abbvie Inc. | Template for a prescription medicine container |
| USD731171S1 (en) | 2013-10-07 | 2015-06-09 | Abbvie Inc. | Template for a prescription medicine container |
| USD731782S1 (en) | 2013-10-07 | 2015-06-16 | Abbvie Inc. | Template for a prescription medicine container |
| AU2015204558B2 (en) | 2014-01-10 | 2020-04-30 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| EP3432879B1 (en) * | 2016-03-22 | 2021-01-06 | Mayo Foundation for Medical Education and Research | Using fatty acid synthase inhibitors to treat fibrosis |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| WO2019028062A1 (en) | 2017-07-31 | 2019-02-07 | Washington University | PIRFENIDONE DERIVATIVES FOR MODULATION OF B-LYMPHOCYTE ACTIVITY AND PROTECTION OF ORGANS |
| US11052021B2 (en) | 2018-03-22 | 2021-07-06 | Abbvie Inc. | Medicine container, method of assembling the container, and method of dispensing the medicine from the container |
| USD930974S1 (en) | 2018-03-22 | 2021-09-21 | Abbvie Inc. | Child-resistant medication container |
| USD930973S1 (en) | 2018-03-22 | 2021-09-21 | Abbvie Inc. | Child-resistant medication container |
| USD882243S1 (en) | 2018-03-26 | 2020-04-28 | Abbvie Inc. | Child-resistant medication container assembly |
| EP3829632A4 (en) * | 2018-07-27 | 2022-05-04 | Société des Produits Nestlé S.A. | Oral immunotherapy unit dose dispensing systems and methods |
| WO2021110805A1 (en) | 2019-12-04 | 2021-06-10 | Idorsia Pharmaceuticals Ltd | Combination of an azetidine lpa1 receptor antagonist with pirfenidone and/or nintedanib for use in the treatment of fibrotic diseases |
| GB2589635B (en) * | 2019-12-06 | 2021-12-01 | Merxin Ltd | Elongate form medicament carrier and medicament dispenser |
| CN117042738A (zh) * | 2021-03-17 | 2023-11-10 | 埃科特莱茵药品有限公司 | 药物剂量系统 |
| WO2023161668A1 (en) | 2022-02-28 | 2023-08-31 | Nuformix Technologies Limited | Compositions and methods for treatment of idiopathic pulmonary fibrosis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US695044A (en) * | 1901-12-28 | 1902-03-11 | Albert E Gibson | Non-refillable bottle. |
| SE9502370D0 (sv) | 1995-06-30 | 1995-06-30 | Astra Ab | Blister pack, especially for drugs, as well as method and device in manufacturing the same |
| US6956044B1 (en) * | 2000-02-21 | 2005-10-18 | Margolin Solomon B | Compositions and methods for treatment of epilepsy |
| ATE452637T1 (de) * | 2001-01-29 | 2010-01-15 | Shionogi & Co | Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält |
| WO2004019863A2 (en) * | 2002-08-28 | 2004-03-11 | Intermune, Inc. | Combination therapy for treatment of fibrotic disorders |
| US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
| CA2525647A1 (en) * | 2003-05-16 | 2005-02-24 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
| US20070092488A1 (en) * | 2003-05-16 | 2007-04-26 | Intermune Inc. | Methods of treating idiopathic pulmonary fibrosis |
| WO2005000227A2 (en) * | 2003-06-06 | 2005-01-06 | Intermune, Inc. | Methods of treating tnf-mediated disorders |
| US20070053877A1 (en) * | 2003-08-21 | 2007-03-08 | Intermune, Inc. | Methods of treating idiopathic pulmonary fibrosis |
| US7407973B2 (en) * | 2003-10-24 | 2008-08-05 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
| EP2305697A3 (en) * | 2005-07-25 | 2011-07-27 | Intermune, Inc. | Macrocyclic inhibitors of Hepatitis C virus replication |
| NZ591443A (en) | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
| US20070203202A1 (en) * | 2005-12-02 | 2007-08-30 | Robinson Cynthia Y | Methods of reducing adverse events associated with pirfenidone therapy |
| US20080003635A1 (en) * | 2006-06-12 | 2008-01-03 | Intermune, Inc. | High Throughput Collagen Synthesis Assay |
| ATE533486T1 (de) * | 2006-06-15 | 2011-12-15 | Shanghai Genomics Inc | Verwendung von pyridonderivaten zur vorbeugung und behandlung von strahlungsbedingter lungenverletzung |
| RU2008152171A (ru) * | 2006-07-05 | 2010-08-10 | Интермьюн, Инк. (Us) | Новые ингибиторы вирусной репликации гепатита с |
| WO2008077068A1 (en) | 2006-12-18 | 2008-06-26 | Intermune, Inc. | Method of providing pirfenidone therapy to a patient |
| US20080287508A1 (en) * | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| WO2008144720A2 (en) * | 2007-05-21 | 2008-11-27 | University Of Washington | Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
-
2007
- 2007-12-18 WO PCT/US2007/087988 patent/WO2008077068A1/en not_active Ceased
- 2007-12-18 ES ES11002040.1T patent/ES2581844T3/es active Active
- 2007-12-18 PL PL07865831T patent/PL2124945T3/pl unknown
- 2007-12-18 SI SI200730641T patent/SI2124945T1/sl unknown
- 2007-12-18 DK DK07865831.7T patent/DK2124945T3/da active
- 2007-12-18 JP JP2009541645A patent/JP2010513320A/ja active Pending
- 2007-12-18 CA CA2667654A patent/CA2667654C/en active Active
- 2007-12-18 EP EP16151564.8A patent/EP3053580B1/en active Active
- 2007-12-18 PL PL16151564T patent/PL3053580T3/pl unknown
- 2007-12-18 ES ES16151564T patent/ES2882956T3/es active Active
- 2007-12-18 DE DE602007014113T patent/DE602007014113D1/de active Active
- 2007-12-18 MX MX2009006526A patent/MX2009006526A/es active IP Right Grant
- 2007-12-18 EP EP11002040.1A patent/EP2338489B1/en not_active Revoked
- 2007-12-18 ES ES07865831T patent/ES2395396T3/es active Active
- 2007-12-18 AT AT07865831T patent/ATE506060T1/de active
- 2007-12-18 EP EP07865831A patent/EP2124945B1/en active Active
- 2007-12-18 US US11/959,338 patent/US7767700B2/en active Active
- 2007-12-18 PT PT07865831T patent/PT2124945E/pt unknown
- 2007-12-18 EP EP12150201A patent/EP2471534A1/en not_active Withdrawn
-
2009
- 2009-04-21 US US12/427,532 patent/US7696236B2/en active Active
-
2010
- 2010-07-07 US US12/831,944 patent/US8420674B2/en active Active
-
2011
- 2011-07-12 CY CY20111100674T patent/CY1111699T1/el unknown
-
2013
- 2013-04-11 US US13/861,099 patent/US20130220871A1/en not_active Abandoned
-
2016
- 2016-07-18 US US15/212,674 patent/US20160324842A1/en not_active Abandoned
-
2018
- 2018-01-18 US US15/874,590 patent/US20180140588A1/en not_active Abandoned
- 2018-09-07 US US16/125,299 patent/US20190000821A1/en not_active Abandoned
-
2019
- 2019-04-24 US US16/393,532 patent/US20190247380A1/en not_active Abandoned
- 2019-12-06 US US16/706,575 patent/US20200113884A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513320A5 (cg-RX-API-DMAC7.html) | ||
| US20200113884A1 (en) | Method of providing pirfenidone therapy to a patient | |
| JP6456890B2 (ja) | ナルトレキソン療法における薬物バイオアベイラビリティの増加 | |
| JP2006504795A5 (cg-RX-API-DMAC7.html) | ||
| JP2015522630A5 (cg-RX-API-DMAC7.html) | ||
| JP2013544290A5 (cg-RX-API-DMAC7.html) | ||
| JP2016138142A (ja) | 大うつ病を有する患者において減量療法を提供する方法 | |
| JP2009518293A5 (cg-RX-API-DMAC7.html) | ||
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| JP2013513652A5 (cg-RX-API-DMAC7.html) | ||
| EP2830605B1 (en) | A combination medicament comprising phenylephrine and paracetamol | |
| US8603523B2 (en) | Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion | |
| JP2020511455A5 (cg-RX-API-DMAC7.html) | ||
| HK1172827A (en) | Method of providing pirfenidone therapy to a patient | |
| HK1227319A1 (en) | Method of providing pirfenidone therapy to a patient | |
| HK1153647B (en) | Method of providing pirfenidone therapy to a patient | |
| HK1133584B (en) | Method of providing pirfenidone therapy to a patient |